CWM
INDV icon

CIBC World Markets’s Indivior Pharmaceuticals INDV Stock Holding History

CIBC World Markets’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$288K Buy
+8,026
New +$245K ﹤0.01% 969
2025
Q2 		$220K Buy
+14,948
New +$174K ﹤0.01% 1235

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC World Markets's INDV Position: Q4 2025 in Review

CIBC World Markets opened a new position in Indivior Pharmaceuticals (INDV) in Q4 2025: 8,026 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #969 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in INDV as recently as Q2 2025.

CIBC World Markets first reported a position in INDV in Q2 2025 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold INDV as of Q4 2025.

  • CIBC World Markets held 8,026 shares of Indivior Pharmaceuticals worth $288K as of Q4 2025.
  • Indivior Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Indivior Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #969 holding.
  • CIBC World Markets first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.